The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome

被引：0
作者：
M. J. Hosseinzadeh-Attar
A. Golpaie
M. Foroughi
F. Hosseinpanah
S. Zahediasl
F. Azizi
机构：
[1] Tehran University of Medical Sciences,Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics
[2] Tehran University of Medical Sciences,Department of Nutrition and Biochemistry, School of Public Health
[3] Shahid Beheshti University of Medical Sciences,Obesity Research Center, Research Institute for Endocrine Sciences
[4] Shahid Beheshti University of Medical Sciences,Endocrine Research Center, Research Institute for Endocrine Sciences
[5] Shahid Beheshti University of Medical Science,Obesity Research Center and Endocrine Research Center, Research Institute for Endocrine Sciences
来源：
Journal of Endocrinological Investigation | 2016年 / 39卷
关键词：
Metabolic syndrome; Visceral adiposity; Visfatin; IL-6; CRP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：917 / 922
页数：5
相关论文
共 243 条
[1]  
Lorenzo C(2007)The national cholesterol education program-adult treatment panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes Diabetes Care 30 8-16
[2]  
Williams K(2005)The metabolic syndrome—a new worldwide definition Lancet 366 1059-184
[3]  
Hunt KJ(2005)The metabolic syndrome: a global public health problem and a new definition Vascular 7 8-2094
[4]  
Haffner SM(2010)Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Mol Cell Endocrinol 314 1-1985
[5]  
Alberti KG(2000)Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102 179-566
[6]  
Zimmet P(2004)Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome Diabetes 53 2087-1565
[7]  
Shaw J(1988)Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 1595-978
[8]  
Zimmet P(2005)Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions J Am Coll Cardiol 46 1978-2222
[9]  
Magliano D(2006)Inflammation and insulin resistance J Clin Invest 116 1793-117
[10]  
Matsuzawa Y(2005)Adipose tissue: a regulator of inflammation Best Pract Res Clin Endocrinol Metab 19 547-E590
12345678910